TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE
Clinical trials for TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE trials appear
Sign up with your email to follow new studies for TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
French trial aims to slash tuberculosis treatment time in half
Disease control Not yet recruitingThis study is testing a new, much shorter 6-month drug combination for adults with multidrug-resistant tuberculosis (MDR-TB) in France. It will compare the new regimen's success rate to the results from patients who received older, much longer treatments (often 18+ months). The g…
Matched conditions: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Personalized dosing aims to tame dangerous TB drug side effects
Disease control Not yet recruitingThis study aims to make a powerful drug for drug-resistant tuberculosis safer. It will test if checking drug levels in a patient's blood and adjusting the dose accordingly can reduce serious side effects, like nerve damage, while still curing the infection. The research will invo…
Matched conditions: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE
Phase: PHASE4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC